BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8050176)

  • 1. The role of natural killer cells in resistance to coccidiosis: investigations in a murine model.
    Smith AL; Rose ME; Wakelin D
    Clin Exp Immunol; 1994 Aug; 97(2):273-9. PubMed ID: 8050176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to coccidiosis: genetic influences on lymphocyte and cytokine responses to infection with Eimeria vermiformis in inbred mice.
    Wakelin D; Rose ME; Hesketh P; Else KJ; Grencis RK
    Parasite Immunol; 1993 Jan; 15(1):11-9. PubMed ID: 8094547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effects of natural killer cells have no significant role in controlling infection with the intracellular protozoon Eimeria vermiformis.
    Rose ME; Hesketh P; Wakelin D
    Infect Immun; 1995 Sep; 63(9):3711-4. PubMed ID: 7642311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
    Flexman JP; Manning LS; Robinson BW
    Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine trophoblast can be killed by lymphokine-activated killer cells.
    Drake BL; Head JR
    J Immunol; 1989 Jul; 143(1):9-14. PubMed ID: 2499634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eimeria vermiformis: differences in the course of primary infection can be correlated with lymphocyte responsiveness in the BALB/c and C57BL/6 mouse, Mus musculus.
    Rose ME; Wakelin D; Hesketh P
    Exp Parasitol; 1990 Oct; 71(3):276-83. PubMed ID: 2209786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice.
    Schito ML; Barta JR
    Infect Immun; 1997 Aug; 65(8):3165-70. PubMed ID: 9234770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants.
    Kawase I; Urdal DL; Brooks CG; Henney CS
    Int J Cancer; 1982 May; 29(5):567-74. PubMed ID: 7095901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma-mediated effects upon immunity to coccidial infections in the mouse.
    Rose ME; Wakelin D; Hesketh P
    Parasite Immunol; 1991 Jan; 13(1):63-74. PubMed ID: 1901641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses to vaccination in strains of mice that differ in susceptibility to coccidiosis.
    Rose ME; Hesketh P; Wakelin D
    Infect Immun; 1996 Jan; 64(1):246-52. PubMed ID: 8557347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal intraepithelial and splenic natural killer cell responses to eimerian infections in inbred chickens.
    Lillehoj HS
    Infect Immun; 1989 Jul; 57(7):1879-84. PubMed ID: 2731975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT.
    Black PL; McKinnon KM; Wooden SL; Ussery MA
    Int J Immunopharmacol; 1996 Nov; 18(11):633-50. PubMed ID: 9089007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L; Lemieux S
    J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
    Bukowski JF; Woda BA; Habu S; Okumura K; Welsh RM
    J Immunol; 1983 Sep; 131(3):1531-8. PubMed ID: 6309965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NK cells in early host response to chlamydial genital infection.
    Tseng CT; Rank RG
    Infect Immun; 1998 Dec; 66(12):5867-75. PubMed ID: 9826367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
    Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
    J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.